Patents by Inventor Maki Arai

Maki Arai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens
    Patent number: 8182820
    Abstract: The subject invention pertains to materials and methods for detecting, preventing and treating retroviral infections in humans and other animals susceptible to infection by retrovirus. It has been discovered that FIV can be transmitted from cats to humans and that the FIV can infect human cells in vivo and that antibodies generated by the infected person cross-react with HIV antigens. Thus, the methods and compositions of the subject invention can be used to detect, prevent and treat FIV infection in humans and other non-feline animals that are susceptible to FIV infection. The methods and compositions of the invention can also be used to prevent and treat infection by HIV in humans.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: May 22, 2012
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Janet K. Yamamoto, Jennifer White Janelle, Barbara Aurea Torres, Maki Arai, Taishi Tanabe, Ruiyu Pu
  • COMBINATION THERAPY FOR TREATMENT OF FIV INFECTION
    Publication number: 20120070489
    Abstract: The present invention pertains to methods for therapeutic and prophylactic treatment of cats against FIV infection. Methods of the present invention utilize a combination of antiretroviral compounds to treat or prevent FIV infection in a feline animal. In one embodiment, the method comprises administering an effective amount of AZT and another nucleoside analog, such as, for example, 3TC to the animal. In another embodiment, cats are given an effective dose(s) of AZT, 3TC, and a retroviral protease inhibitor.
    Type: Application
    Filed: September 14, 2011
    Publication date: March 22, 2012
    Inventors: BEN M. DUNN, JANET K. YAMAMOTO, MAKI ARAI
  • Materials and Methods for Detecting, Preventing, and Treating Retroviral Infection
    Publication number: 20090274725
    Abstract: The subject invention pertains to materials and methods for detecting, preventing and treating retroviral infections in humans and other animals susceptible to infection by retrovirus. It has been discovered that FIV can be transmitted from cats to humans and that the FIV can infect human cells in vivo and that antibodies generated by the infected person cross-react with HIV antigens. Thus, the methods and compositions of the subject invention can be used to detect, prevent and treat FIV infection in humans and other non-feline animals that are susceptible to FIV infection. The methods and compositions of the invention can also be used to prevent and treat infection by HIV in humans.
    Type: Application
    Filed: March 19, 2009
    Publication date: November 5, 2009
    Inventors: Janet K. Yamamoto, Jennifer White Janelle, Barbara Aurea Torres, Maki Arai, Taishi Tanabe, Ruiyu Pu
  • Combination Therapy for Treatment of FIV Infection
    Publication number: 20090197827
    Abstract: The present invention pertains to methods for therapeutic and prophylactic treatment of cats against FIV infection. Methods of the present invention utilize a combination of antiretroviral compounds to treat or prevent FIV infection in a feline animal. In one embodiment, the method comprises administering an effective amount of AZT and another nucleoside analog, such as, for example, 3TC to the animal. In another embodiment, cats are given an effective dose(s) of AZT, 3TC, and a retroviral protease inhibitor.
    Type: Application
    Filed: December 3, 2008
    Publication date: August 6, 2009
    Inventors: Ben M. Dunn, Janet K. Yamamoto, Maki Arai
  • Combination therapy for treatment of FIV infection
    Publication number: 20050159389
    Abstract: The present invention pertains to methods for therapeutic and prophylactic treatment of cats against FIV infection. Methods of the present invention utilize a combination of antiretroviral compounds to treat or prevent FIV infection in a feline animal. In one embodiment, the method comprises administering an effective amount of AZT and another nucleoside analog, such as, for example, 3TC to the animal. In another embodiment, cats are given an effective dose(s) of AZT, 3TC, and a retroviral protease inhibitor.
    Type: Application
    Filed: January 4, 2005
    Publication date: July 21, 2005
    Inventors: Ben Dunn, Janet Yamamoto, Maki Arai
  • Combination therapy for treatment of FIV infection
    Patent number: 6875773
    Abstract: The present invention pertains to methods for therapeutic and prophylactic treatment of cats against FIV infection. Methods of the present invention utilize a combination of antiretroviral compounds to treat or prevent FIV infection in a feline animal. In one embodiment, the method comprises administering an effective amount of AZT and another nucleoside analog, such as, for example, 3TC to the animal. In another embodiment, cats are given an effective dose(s) of AZT, 3TC, and a retroviral protease inhibitor.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: April 5, 2005
    Inventors: Ben M. Dunn, Janet K. Yamamoto, Maki Arai
  • Materials and methods for detecting, preventing, and treating retroviral infection
    Publication number: 20030091987
    Abstract: The subject invention pertains to materials and methods for detecting, preventing and treating retroviral infections in humans and other animals susceptible to infection by retrovirus. It has been discovered that FIV can be transmitted from cats to humans and that the FIV can infect human cells in vivo and that antibodies generated by the infected person cross-react with HIV antigens. Thus, the methods and compositions of the subject invention can be used to detect, prevent and treat FIV infection in humans and other non-feline animals that are susceptible to FIV infection. The methods and compositions of the invention can also be used to prevent and treat infection by HIV in humans.
    Type: Application
    Filed: February 22, 2002
    Publication date: May 15, 2003
    Inventors: Janet K. Yamamoto, Jennifer White Janelle, Barbara Aurea Torres, Maki Arai, Taishi Tanabe, Ruiyu Pu